-+ 0.00%
-+ 0.00%
-+ 0.00%

OCULAR THERAPEUTIX™ INVESTOR DAY TO HIGHLIGHT U.S. FDA ALIGNMENT ON AXPAXLI™ NDA WITH SUBMISSION PLANNED FOR FOURTH QUARTER 2026

Reuters·06/17/2026 12:45:00

Please log in to view news